People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is largely due to excitement over its [long-acting HIV prevention drug]( ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...

Descovy also treats HIV in certain people. This article covers topics such as side effects, dosage, and more. Descovy belongs to a drug class called nucleoside reverse transcriptase inhibitors.

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

Without U.S. funding, distribution from the warehouse, which stocks all U.S. government-donated HIV medicine to Kenya, has ceased, leaving supplies of some drugs worryingly low, according to a ...

A child sits as nurse Sarah Mleli prepares to dispense antiretroviral ARV drugs used to prevent HIV from replicating, at the Nyumbani Children's Home, which cares for more than 100 children with ...